Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of...
Read moreNeurim Pharmaceuticals and Exeltis announced a license agreement in which Exeltis will obtain exclusive marketing rights for Neurim’s new Rx...
Read moreTo help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific,...
Read moreQR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s (AD), Parkinson’s...
Read moreJazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Read moreOn February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role...
Read moreThe store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts,...
Read moreAs part of the 2016 Radiological Society of North America Annual Meeting (RSNA), Royal Philips announced the introduction of IntelliSpace...
Read moreViiV Healthcare presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq...
Read moreMerck, a leading science and technology company announced that the EMA to request the company for marketing approval for its...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.